Physician profile
Princessa Johnson
NPI 1295754596
$1,095.43
in general payments reported to CMS, 2019-2025
13 companies · $62.29 in 2025
The $62.29 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $133 · 2021: $149 · 2022: $213 · 2023: $222 · 2024: $123 · 2025: $62.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $487.35 | 2019-2023 | |
| Pfizer INC. | $131.53 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $119.32 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $92.32 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $54.99 | 2019-2020 | |
| Hologic Sales and Service, LLC | $44.41 | 2021-2023 | Aptima |
| Myovant Sciences INC. | $41.68 | 2022 | |
| Roche Diagnostics Corporation | $36.29 | 2019 | |
| Novo Nordisk INC | $24.00 | 2024 | Wegovy |
| Therapeuticsmd, INC. | $21.48 | 2020 | |
| Lupin INC. | $14.52 | 2020 | |
| Exact Sciences Corporation | $14.15 | 2025 | Cologuard Collection Kit |
| Exeltis, USA INC. | $13.39 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Princessa Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.